Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


08.07.2024

2 AJR Am J Roentgenol
2 Am J Clin Oncol
1 Ann Surg
9 Ann Surg Oncol
3 BMC Cancer
2 Br J Cancer
8 Breast Cancer Res
6 Breast Cancer Res Treat
1 Cancer
2 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
1 Cancer Res
1 Clin Cancer Res
1 Clin Exp Metastasis
1 Eur J Cancer
1 Eur J Surg Oncol
1 Eur Radiol
2 Gene
1 Int J Cancer
2 Int J Radiat Oncol Biol Phys
1 J Biol Chem
1 J Clin Oncol
1 J Nucl Med
2 JAMA
2 NPJ Breast Cancer
2 Oncol Rep
3 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiother Oncol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. GARRETT HV, Bennett DL
    Axillary Seed Localization With Digital Breast Tomosynthesis Guidance: A Novel Technique Using Anterior Approach and Modified Stereotactic Guidance.
    AJR Am J Roentgenol. 2024;222:e2430994.
    PubMed        

  2. CROWLEY C, Bahl M
    Radial Scars on Screening Digital Breast Tomosynthesis: Upstaging Rates and Management Strategies.
    AJR Am J Roentgenol. 2024;222:e2430845.
    PubMed         Abstract available


    Am J Clin Oncol

  3. PUJARI L, Suresh A, Chowdhury Z, Pradhan S, et al
    Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy.
    Am J Clin Oncol. 2024 Jul 4. doi: 10.1097/COC.0000000000001129.
    PubMed         Abstract available

  4. QURESHI Z, Altaf F, Jamil A, Siddique R, et al
    Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer: An Updated Systematic Review and Meta-Analysis of Clinical Trials.
    Am J Clin Oncol. 2024 Jul 2. doi: 10.1097/COC.0000000000001126.
    PubMed         Abstract available


    Ann Surg

  5. OSHI M, Wu R, Khoury T, Gandhi S, et al
    Infiltration of Common Myeloid Progenitor (CMP) Cells is Associated With Less Aggressive Tumor Biology, Lower Risk of Brain Metastasis, Better Response to Immunotherapy and Higher Patient Survival in Breast Cancer.
    Ann Surg. 2024 Jul 1. doi: 10.1097/SLA.0000000000006428.
    PubMed         Abstract available


    Ann Surg Oncol

  6. PILEWSKIE M, Eroglu I, Sevilimedu V, Le T, et al
    Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development.
    Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15633.
    PubMed         Abstract available

  7. SHAH C, Boyages J, Koelmeyer L, Chen SL, et al
    Timing of Breast Cancer Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure.
    Ann Surg Oncol. 2024 Jul 4. doi: 10.1245/s10434-024-15706.
    PubMed         Abstract available

  8. BHIMANI F, Feldman S, McEvoy M
    ASO Author Reflections: Evaluating the Effectiveness of Axillary Reverse Mapping in Reducing Breast Cancer-Related Lymphedema Among Ethnically Diverse Patients.
    Ann Surg Oncol. 2024 Jul 4. doi: 10.1245/s10434-024-15663.
    PubMed        

  9. BEAULIEU-JONES BR, Ha EJ, Fefferman A, Wang J, et al
    ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15647.
    PubMed        

  10. HUA T, Mendoza S, McCririe-Balcom M, Kelley J, et al
    Routine Clinical Breast Examination Is a Low-Yield Practice Among Women at High Risk of Breast Cancer.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15702.
    PubMed         Abstract available

  11. MCINTOSH SA, Mactier M, Fairhurst K, Gath J, et al
    ASO Visual Abstract: Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15683.
    PubMed        

  12. MISHRA A, Deo SVS, Kumar N, Bansal B, et al
    ASO Visual Abstract: A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low-Middle Income Country.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15696.
    PubMed        

  13. SHEN A, Qiang W, Zhao H, Han G, et al
    Contemporaneous Symptom Networks of Breast Cancer-Related Upper Limb Lymphedema: A Network Analysis.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15676.
    PubMed         Abstract available

  14. JONNALAGADDA P, Rahurkar S
    ASO Author Reflections: Disparities in Triple-Negative Breast Cancer Care: Are Some Patients Being Overlooked?
    Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15640.
    PubMed        


    BMC Cancer

  15. PENG J, Lin Y, Sheng X, Yuan C, et al
    Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy.
    BMC Cancer. 2024;24:789.
    PubMed         Abstract available

  16. PIAO YJ, Kim HS, Kim H, Shen J, et al
    SerpinB2 deficiency is associated with delayed mammary tumor development and decreased pro-tumorigenic macrophage polarization.
    BMC Cancer. 2024;24:792.
    PubMed         Abstract available

  17. MRABTI H, Sauvaget C, Bendahhou K, Selmouni F, et al
    Breast cancer treatment and its impact on survival in Morocco: a study over a decade.
    BMC Cancer. 2024;24:786.
    PubMed         Abstract available


    Br J Cancer

  18. POSSENTI I, Scala M, Carreras G, Bagnardi V, et al
    Exposure to second-hand smoke and breast cancer risk in non-smoking women: a comprehensive systematic review and meta-analysis.
    Br J Cancer. 2024 Jun 28. doi: 10.1038/s41416-024-02732.
    PubMed         Abstract available

  19. BOMAN C, Liu X, Eriksson Bergman L, Sun W, et al
    A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression.
    Br J Cancer. 2024 Jun 28. doi: 10.1038/s41416-024-02777.
    PubMed         Abstract available


    Breast Cancer Res

  20. FIFIELD BA, Vusich J, Haberfellner E, Andrechek ER, et al
    Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis.
    Breast Cancer Res. 2024;26:106.
    PubMed         Abstract available

  21. GAO H, Wei L, Indulkar S, Nguyen TTL, et al
    Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy.
    Breast Cancer Res. 2024;26:111.
    PubMed         Abstract available

  22. YANG X, Liu Q, Guo Z, Yang X, et al
    Promoter profiles in plasma CfDNA exhibits a potential utility of predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients.
    Breast Cancer Res. 2024;26:112.
    PubMed         Abstract available

  23. SUBRAMANYAN LV, Rasheed SAK, Wang L, Ghosh S, et al
    GNA13 suppresses proliferation of ER+ breast cancer cells via ERalpha dependent upregulation of the MYC oncogene.
    Breast Cancer Res. 2024;26:113.
    PubMed         Abstract available

  24. XIAO D, Zhang M, Qu Y, Su X, et al
    Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target.
    Breast Cancer Res. 2024;26:110.
    PubMed         Abstract available

  25. HENG YJ, Baker GM, Fein-Zachary VJ, Guzman-Arocho YD, et al
    Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals.
    Breast Cancer Res. 2024;26:109.
    PubMed         Abstract available

  26. SINEVICI N, Edmonds CE, Dontchos BN, Wang G, et al
    A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidance.
    Breast Cancer Res. 2024;26:107.
    PubMed         Abstract available

  27. WANG C, Nagayach A, Patel H, Dao L, et al
    Utilizing human cerebral organoids to model breast cancer brain metastasis in culture.
    Breast Cancer Res. 2024;26:108.
    PubMed         Abstract available


    Breast Cancer Res Treat

  28. OZ O, Irmak Yuzuguldu R, Yazici A, Kocatepe Cavdar D, et al
    The differences between pure and mixed invasive micropapillary breast cancer: the epithelial-mesenchymal transition molecules and prognosis.
    Breast Cancer Res Treat. 2024 Jul 2. doi: 10.1007/s10549-024-07384.
    PubMed         Abstract available

  29. FANG T, Hu S, Song X, Wang J, et al
    Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.
    Breast Cancer Res Treat. 2024 Jul 3. doi: 10.1007/s10549-024-07374.
    PubMed         Abstract available

  30. MATHESON J, Elder K, Nickson C, Park A, et al
    Contrast-enhanced mammography for surveillance in women with a personal history of breast cancer.
    Breast Cancer Res Treat. 2024 Jul 4. doi: 10.1007/s10549-024-07419.
    PubMed         Abstract available

  31. MAGNONI F, Bianchi B, Pagan E, Corso G, et al
    Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study.
    Breast Cancer Res Treat. 2024 Jul 4. doi: 10.1007/s10549-024-07422.
    PubMed         Abstract available

  32. FEFFERMAN ML, Stump TK, Thompson D, Simovic S, et al
    Patient-reported observations on medical procedure timeliness (PROMPT) in breast cancer: a qualitative study.
    Breast Cancer Res Treat. 2024 Jul 4. doi: 10.1007/s10549-024-07406.
    PubMed         Abstract available

  33. MEZZANOTTE-SHARPE J, ONeill A, Mayer IA, Arteaga CL, et al
    A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
    Breast Cancer Res Treat. 2024 Jul 5. doi: 10.1007/s10549-024-07417.
    PubMed         Abstract available


    Cancer

  34. REINER AS, Knight JA, John EM, Lynch CF, et al
    Agreement of medical record abstraction and self-report of breast cancer treatment with an extended recall window.
    Cancer. 2024 Jun 28. doi: 10.1002/cncr.35459.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  35. OH H, Yaghjyan L, Heng YJ, Rosner B, et al
    Associations of Early-Life and Adult Anthropometric Measures with the Expression of Stem Cell Markers CD44, CD24, and ALDH1A1 in Women with Benign Breast Biopsies.
    Cancer Epidemiol Biomarkers Prev. 2024;33:933-943.
    PubMed         Abstract available

  36. ABUBAKAR M, Ahearn TU, Duggan MA, Lawrence S, et al
    Contribution of pre-diagnostic host factors to shaping the stromal microenvironment of breast cancer among sub-Saharan African women.
    Cancer Epidemiol Biomarkers Prev. 2024 Jul 3. doi: 10.1158/1055-9965.EPI-24-0390
    PubMed         Abstract available


    Cancer Lett

  37. PERDRIX ROSELL A, Maiques O, Martin JAJ, Chakravarty P, et al
    Corrigendum to "Early functional mismatch between breast cancer cells and their tumour microenvironment suppresses long term growth" [Cancer Lett. 544 (2022), 215800].
    Cancer Lett. 2024 Jul 1:217078. doi: 10.1016/j.canlet.2024.217078.
    PubMed        

  38. WAN YX, Qi XW, Lian YY, Liu ZY, et al
    Electroacupuncture Facilitates Vascular Normalization by Inhibiting Glyoxalase1 in Endothelial Cells to Attenuate Glycolysis and Angiogenesis in Triple-Negative Breast Cancer.
    Cancer Lett. 2024 Jun 28:217094. doi: 10.1016/j.canlet.2024.217094.
    PubMed         Abstract available


    Cancer Res

  39. LEE G, Wong C, Cho A, West JJ, et al
    E-cadherin Induces Serine Synthesis to Support Progression and Metastasis of Breast Cancer.
    Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-23-3082.
    PubMed         Abstract available


    Clin Cancer Res

  40. STEARNS V, Jegede OA, Chang VT, Skaar TC, et al
    A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11.
    Clin Cancer Res. 2024;30:2709-2718.
    PubMed         Abstract available


    Clin Exp Metastasis

  41. GRUBE M, Dimmler A, Schmaus A, Saup R, et al
    Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice.
    Clin Exp Metastasis. 2024;41:251-266.
    PubMed         Abstract available


    Eur J Cancer

  42. HASLAM A, Ranganathan S, Prasad V, Olivier T, et al
    CDK4/6 inhibitors as adjuvant therapy in early breast cancer? Uncertain benefits, guaranteed harms.
    Eur J Cancer. 2024;207:114192.
    PubMed         Abstract available


    Eur J Surg Oncol

  43. SCHIAVONE A, Ventimiglia F, Zarba Meli E, Taffurelli M, et al
    Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus.
    Eur J Surg Oncol. 2024;50:108351.
    PubMed         Abstract available


    Eur Radiol

  44. VAN DER VOORT A, van der Hoogt KJJ, Wessels R, Schipper RJ, et al
    Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer.
    Eur Radiol. 2024 Jul 5. doi: 10.1007/s00330-024-10857.
    PubMed         Abstract available


    Gene

  45. ABDULLAH AR, Gamal El-Din AM, Ismail Y, El-Husseiny AA, et al
    The FSCN1 gene rs2966447 variant is associated with increased serum fascin-1 levels and breast cancer susceptibility.
    Gene. 2024 Jul 2:148743. doi: 10.1016/j.gene.2024.148743.
    PubMed         Abstract available

  46. ALOUFI A, Aubee J, Vargas KM, Apprey V, et al
    Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women.
    Gene. 2024 Jun 28:148695. doi: 10.1016/j.gene.2024.148695.
    PubMed         Abstract available


    Int J Cancer

  47. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  48. ZHOU YY, Li YN, Xu JF, Chen B, et al
    Rapid Selection of Patients Suitable for Deep Inspiration Breath-Hold Using an Automatic Delineating System and RapidPlan Model in Left Breast Cancer Patients undergoing Adjuvant Radiotherapy with IMRT.
    Int J Radiat Oncol Biol Phys. 2024 Jun 26:S0360-3016(24)00739.
    PubMed         Abstract available

  49. YIT LFN, Quek ZHS, Tan JYT, Tan BF, et al
    Curative Approaches for Metaplastic Breast Cancer: A Retrospective Cohort Outcome Review.
    Int J Radiat Oncol Biol Phys. 2024 Jun 29:S0360-3016(24)00751.
    PubMed         Abstract available


    J Biol Chem

  50. GUO Q, Zhao J, Li Y, Zhang C, et al
    CK2-HTATSF1-TOPBP1 signaling axis modulates tumor chemotherapy response.
    J Biol Chem. 2024;300:107377.
    PubMed         Abstract available


    J Clin Oncol

  51. RAMCHAND SK, Ghasem-Zadeh A, Hoermann R, White S, et al
    Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial.
    J Clin Oncol. 2024 Jul 2:JCO2302309. doi: 10.1200/JCO.23.02309.
    PubMed         Abstract available


    J Nucl Med

  52. PHAM TT, Chenoweth A, Patel N, Banu A, et al
    In Vivo PET Imaging of (89)Zr-Labeled Natural Killer Cells and the Modulating Effects of a Therapeutic Antibody.
    J Nucl Med. 2024 Jun 6:jnumed.124.267876. doi: 10.2967/jnumed.124.267876.
    PubMed         Abstract available


    JAMA

  53. TU H, Zhang Y, You Z
    Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer.
    JAMA. 2024 Jul 3. doi: 10.1001/jama.2024.10480.
    PubMed        

  54. LEON-FERRE RA, Salgado R, Jonas SF
    Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer-Reply.
    JAMA. 2024 Jul 3. doi: 10.1001/jama.2024.10483.
    PubMed        


    NPJ Breast Cancer

  55. CHEANG MCU, Rimawi M, Johnston S, Jacobs SA, et al
    Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies.
    NPJ Breast Cancer. 2024;10:54.
    PubMed         Abstract available

  56. SHEN S, Salehi E, White C, Chen Y, et al
    Evaluation of a mobile behavior change program for weight loss in breast cancer survivors.
    NPJ Breast Cancer. 2024;10:53.
    PubMed         Abstract available


    Oncol Rep

  57. QIU Y, Liu Y, Li WH, Zhang HQ, et al
    [Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT?related genes Snail and E?cadherin.
    Oncol Rep. 2024;52:111.
    PubMed         Abstract available

  58. PENG X, Ma L, Chen X, Tang F, et al
    Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer.
    Oncol Rep. 2024;52:110.
    PubMed         Abstract available


    PLoS One

  59. TSUTSUMI E, Macy AM, LoBello J, Hastings KT, et al
    Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer.
    PLoS One. 2024;19:e0304194.
    PubMed         Abstract available

  60. GODINA C, Khazaei S, Belting M, Vallon-Christersson J, et al
    High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome.
    PLoS One. 2024;19:e0305222.
    PubMed         Abstract available

  61. DONG J, Wang D, Zhong S
    Effects of different exercise types and cycles on pain and quality of life in breast cancer patients: A systematic review and network meta-analysis.
    PLoS One. 2024;19:e0300176.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  62. ZHOU Q, Yu H, Chen Y, Ren J, et al
    The CRL3(KCTD10) ubiquitin ligase-USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11.
    Proc Natl Acad Sci U S A. 2024;121:e2320655121.
    PubMed         Abstract available


    Radiother Oncol

  63. REFSGAARD L, Skarso Buhl E, Yates E, Maae E, et al
    Evaluating Danish Breast Cancer Group locoregional radiotherapy guideline adherence in clinical treatment data 2008-2016: The DBCG RT Nation study.
    Radiother Oncol. 2024 Apr 25:110289. doi: 10.1016/j.radonc.2024.110289.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.